ECG in Hypokalemia

Pathophysiological basis of cardiac involvement

The pathogenesis of myocardial damage in hypokalemia is closely linked to a complex of metabolic and vascular shifts. According to clinical data, such electrolyte disorders may develop in parallel with a decrease in sodium levels (particularly against the background of aldosterone deficiency).

A drop in blood potassium concentration rarely acts in isolation. It is exacerbated by microcirculatory disorders, tissue hypoxia, and concurrent arterial hypertension. This entire pathophysiological chain leads to severe dystrophic changes in the myocardium. The trophic state of the cardiac tissue suffers, which inevitably affects its electrical activity and causes pronounced conduction disorders. In such cases, patients are indicated for an ECG, and if auscultation reveals abnormalities, an echocardiography (EchoCG) should be performed to detail the degree of damage.

Key ECG changes

Potassium deficiency specifically distorts ventricular repolarization processes. The classic ECG pattern includes several mandatory components that are important to recognize:

• ST segment: marked depression relative to the isoelectric line is observed.
• T wave: loses amplitude, flattening occurs. Frequently, the T wave becomes biphasic.
• U wave: one of the most striking signs. A noticeable pathological U wave appears on the tracing.
• Voltage: a general decrease in the voltage of the electrocardiogram waves is characteristic.

In addition to changes in the curve itself, electrolyte deficiency acts as a powerful trigger for rhythm disorders. Various arrhythmias, including bradycardia, are frequently recorded in patients.

Differential diagnosis

Changes in hypokalemia must be distinguished from other metabolic disorders and drug side effects that can mimic ischemia:

1. Hyperkalemia: presents the opposite picture. The T wave becomes tall, symmetrical, "peaked", and has a narrow base.
2. Cardiac glycoside effect: drugs cause a specific "scoop-like" ST depression, decreased T-wave amplitude, and shortened Q-T interval. With prolonged use, a powerful arrhythmogenic effect is possible (from ventricular extrasystoles to non-paroxysmal tachycardia and conduction blocks).
3. Hypercalcemia: primarily manifests as altered time intervals (Q-T shortening).
4. Cerebrogenic changes: in acute central nervous system pathologies (strokes, hemorrhages), repolarization disorders can occur, visually mimicking primary cardiac pathology.

Associated disorders and management

Hypokalemia is often associated with other systemic pathologies. For example, if cortisol deficiency is involved in the pathogenesis, carbohydrate metabolism suffers, leading to hypoglycemia. Clinically, this is expressed by tachycardia, weakness spells, sweating, and a sensation of hunger.

Hypercoagulation, thrombosis, and thromboangiitis obliterans are possible on the part of the vascular system. Peripheral edema, left ventricular hypertrophy, and circulatory failure are frequently observed.

Clinical management: detecting signs of hypokalemia on an ECG requires timely diagnosis and the prescription of corrective therapy strictly in conjunction with a cardiologist. To clarify the nature of arrhythmias, the diagnostic workup may be expanded with Holter ECG monitoring or phonocardiography (PCG).

Class and exam questions

What else to study on this topic

• ECG criteria and differential diagnosis of hyperkalemia.
• Effect of cardiac glycosides on the myocardium: arrhythmogenic effect and "scoop-like" ST depression.
• Cerebrogenic ECG changes in strokes and hemorrhages.
• Pathogenesis of myocardial dystrophic changes against the background of hypoxia.
• Interrelationship of electrolyte disorders with carbohydrate metabolism (effect of cortisol).

Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.